Delinia is formerly owned by Sofinnova Partners, through Sofinnova Capital VIII, since 2016.

When did Sofinnova Partners acquire Delinia?

Sofinnova Partners acquired Delinia in 2016 and exited after 1 year.

Has Delinia been sold?

Yes. Delinia was exited in 2017 via Trade Sale.

Home/Companies/Biotech/Delinia

Delinia

Biotech·

UK·Exited 2017·Held 1yr

Delinia is a healthcare / biotech company, headquartered in United Kingdom.

Entry

2016

Hold

1yr

Exit

2017

Est. EV

–

Investor

Sofinnova Partners

Key facts

HQUnited Kingdom

SectorHealthcare / Biotech

UK biotech developing Treg-potentiating therapeutics for autoimmune diseases, acquired by Celgene in 2017. Acquired by Celgene Jan 2017 for…Read full notes

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Exit details: type, year, MOIC (buyer on Pro)

Start free

Already a member? Sign in

More from Sofinnova Capital VIII

Other portfolio companies in the same fund.

Corvidia Therapeutics

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Last updated April 2026 · Sourced from public filings